InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: DonDonDonDon post# 154988

Friday, 03/26/2021 6:22:27 PM

Friday, March 26, 2021 6:22:27 PM

Post# of 233221
I will post this again ..It used to be about 6 days that there was reduction in hospitalization with lenzilumab , as per this older article .

When I listened lately to the CC , CEO said that with improved treatment generally in covid , length of hospitalization on average came to one day less with Lenzilumab compared with other treatments ..and this is why they changed for the second time primary endpoint ..

This is a reason CEO said why length of hospitalization is no longer primary endpoint in Lenzilumab study ..
I actually cant think of any other study changing 3 times primary endpoint in one study...

Leronlimab in their study showed 5.5 days reduced length of hospitalization,
compared with other treatments in severe and critical patients...

....Statistically Significant .....



GLTA longs
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News